Navigation Links
SkinMedica(R) Launches New Informational Web Site
Date:6/24/2008

CARLSBAD, Calif., June 24 /PRNewswire/ -- SkinMedica(R), Inc., launches a new informational web site, TNSRecoveryComplex.com, centered around the top-selling product, TNS Recovery Complex(R). The site is designed to communicate with and provide consumers with a greater understanding of the science and efficacy of NouriCel-MD(R), the active ingredient in TNS Recovery Complex(R), and the growing TNS(R) Collection.

TNSRecoveryComplex.com features eight pages -- where visitors can learn more about the ingredients, products and the brand in the click of a button -- including "Our Secret" explaining where the idea of TNS Recovery Complex stemmed from; "Our Formula" describes NouriCel-MD(R); "The Benefits" of TNS(R); "The Collection" provides an overview of all six SkinMedica product offerings by category; "Find TNS" tells visitors where they can locate a physician's office or medically supervised spa; "FAQ" features the top frequently asked questions; "Contact" for further inquiries; and "Login" for medical professionals only. The site, http://www.TNSRecoveryComplex.com is currently live.

Screen Grab from the TNSRecoveryComplex.com Home Page:

(Photo: http://www.newscom.com/cgi-bin/prnh/20080624/LATU014)

SkinMedica, Inc. is an aesthetic and pharmaceutical company focused on developing, acquiring and commercializing products that improve the appearance of skin and treat dermatologic conditions and diseases.

About SkinMedica

SkinMedica is a privately held specialty pharmaceutical company marketing both prescription and cosmeceutical dermatology products. SkinMedica's Desonate(R) (desonide) Gel 0.05% is indicated for the treatment of mild-to-moderate atopic dermatitis; EpiQuin(R) Micro (4% hydroquinone) cream is indicated for melasma and postinflammatory hyperpigmentation; VANIQA(R) (eflornithine hydrochloride) Cream, 13.9%, is the only FDA-approved prescription product for the treatment of unwanted facial hair in women; and NeoBenz(R) Micro Cream and NeoBenz(R) Micro SD (single dose) are the only benzoyl peroxide prescription products that contain a patented gradual-release formulation of benzoyl peroxide to treat acne. The company's full line of cosmeceutical products, which is sold through physicians, includes TNS Recovery Complex(R) with NouriCel-MD(R) to help improve the health and appearance of aging skin. SkinMedica is based in Carlsbad, California. For more information, visit http://www.skinmedica.com.

SkinMedica cautions you that statements included in this press release that are not a description of historical facts may be forward-looking statements. The inclusion of forward-looking statements should not be regarded as a representation by SkinMedica that any of its plans will be achieved. Actual results may differ materially from those set forth in this release due to the risks and uncertainties inherent in SkinMedica's business due to a number of factors, including: (i) we and our products face significant competition; (ii) if we do not successfully manage any growth we experience, we may experience increased expenses without corresponding revenue increases; (iii) we are dependent on third parties for supply of all the products we offer; (iv) unexpected adverse side effects or inadequate therapeutic efficacy of our products could delay or prevent product development or commercialization, or could result in recalls or product liability claims; and (v) we may not be able to identify appropriate acquisition, licensing, or co-promotion candidates in the future or to take advantage of the opportunities we identify. All forward-looking statements are qualified in their entirety by this cautionary statement and SkinMedica undertakes no obligation to revise or update this news release to reflect events or circumstances after the date hereof.

SkinMedica(R), Desonate(R), EpiQuin(R) Micro, NeoBenz(R) Micro, NouriCel-MD(R), TNS Recovery Complex(R), and VANIQA(R) are registered trademarks of SkinMedica, Inc.

CONTACT INFORMATION:

Lisa O'Connor

SkinMedica, Inc.

(760) 448-3707

loconnor@skinmedica.com

http://www.skinmedica.com


'/>"/>
SOURCE SkinMedica, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
2. UPMC Health Plan Launches New Personal Health Record
3. HealthInsuranceFinders.com Launches Video Contest for Young Directors
4. Academy of General Dentistry Launches Campaign to Focus on Tooth Erosion
5. Keeping Kids Healthy and Fit: The New York Kids Club Launches a Revolutionary New Fitness Program
6. Patient Advocate Foundation Launches Program to Help Uninsured Virginians with Chronic, Debilitating and Life-Threatening Illness Access Quality Healthcare
7. Mannatech Launches Phase One of New Sales and Training Tools
8. Coalition for Pulmonary Fibrosis Launches Aggressive Ad Campaign Directed at United States Congress
9. Actavis Launches Carvedilol Tablets in the U.S.
10. MedQuist Re-launches New, Improved Web Site
11. Elsevier launches new journal: Stem Cell Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... Elisabete ... has been honored by Enterprising Women magazine as one of its 2017 Enterprising ... women business owners. Winners have demonstrated that they have fast-growth businesses, mentor or ...
(Date:4/26/2017)... ... 2017 , ... Miami native and local periodontist Dr. John Paul Gallardo ... imagined back in 1991 that this journey would have taken me into so many ... years, Dr. Gallardo has pioneered implant dentistry innovation, evolving into an internationally recognized leader ...
(Date:4/26/2017)... ... April 26, 2017 , ... New SUPRO® XT55 Isolated ... beverages by helping beverage manufacturers more effectively manage protein costs. “Soy protein has ... as well as more stable pricing over time. Now it’s even more relevant ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... cream that’s the first in a new class of photodynamic cosmetics (PDC). , ... of skin, visibly reduce outward signs of aging, and minimize the appearance of ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... committed to raising awareness for Duchenne muscular dystrophy, and funding for Duchenne ... (cardiosphere-derived cells) Phase I/II HOPE clinical trial in Duchenne announced today. , ...
Breaking Medicine News(10 mins):
(Date:4/24/2017)... 2017 SW Safety Solutions, Inc., the industry,s ... the release of the latest advancement in workplace single-use ... of leading edge nitrile glove technology features SW,s patent ... tactile grip on wet and oily surfaces and the ... and a suite of other advanced SW technologies, the ...
(Date:4/21/2017)... , April 21, 2017 Halo Labs announces ... biopharmaceutical particle analysis system called the Horizon at PEGS ... 1st. The new system analyzes sub visible particulate matter ... rapid particle screening as early as candidate selection and ... leading biopharma contract research organization Elion Labs ...
(Date:4/20/2017)... Texas , April 20, 2017  Vivify Health, ... mobile devices, has been awarded a very significant patent ... via EMRs to continual care via digital health.  This ... key intellectual property and further secures Vivify,s position as ... launched in 2009, was the first company to apply ...
Breaking Medicine Technology: